E Altunisik1, A H Baykan2, S Sahin3, E Aydin4, S M Erturk5. 1. From the Department of Neurology (E. Altunisik). 2. Radiology (A.H.B.), Adiyaman University Faculty of Medicine, Adiyaman, Turkey drbaykan@yahoo.com. 3. Department of Radiology (S.S.), Adiyaman Training and Research Hospital, Adiyaman, Turkey. 4. Department of Radiology (E. Aydin), Baskent University Faculty of Medicine, Izmir, Turkey. 5. Department of Radiology (S.M.E), Istanbul University Faculty of Medicine, Istanbul, Turkey.
Abstract
BACKGROUND AND PURPOSE: Anosmia or hyposmia, often accompanied by changes in taste, is recognized as a common symptom that can assist in the diagnosis of coronavirus disease 2019 (COVID-19). The pathogenesis of olfactory dysfunction in COVID-19 is not yet fully understood. MR imaging represents a useful anatomic imaging method for the evaluation of olfactory dysfunction associated with varying etiologies, including viral infection, trauma, and neurodegenerative processes. This case-control study was conducted to compare quantitative measurements of olfactory anatomic structures between patients diagnosed with COVID-19 associated with persistent olfactory dysfunction and healthy controls. MATERIALS AND METHODS: This study has a retrospective design. Cranial MR imaging was performed on all participants in both the patient and control groups. The bilateral olfactory bulb volume, olfactory tract length, and olfactory sulcus depth were measured in all patients. RESULTS: A total of 116 people aged 18-60 years, including 36 patients diagnosed with COVID-19 and 80 controls, were included in the study. All measured values were compared between the patient and control groups. The right, left, and total olfactory bulb volume values were significantly lower in the patient group than in the control group. The patient group also had significantly lower right and left olfactory sulcus depth and olfactory tract length values compared with those in the control group. CONCLUSIONS: MR imaging findings can be used to demonstrate olfactory injury in patients with COVID-19. The olfactory pathway may represent an alternative route for virus entry into the central nervous system.
BACKGROUND AND PURPOSE: Anosmia or hyposmia, often accompanied by changes in taste, is recognized as a common symptom that can assist in the diagnosis of coronavirus disease 2019 (COVID-19). The pathogenesis of olfactory dysfunction in COVID-19 is not yet fully understood. MR imaging represents a useful anatomic imaging method for the evaluation of olfactory dysfunction associated with varying etiologies, including viral infection, trauma, and neurodegenerative processes. This case-control study was conducted to compare quantitative measurements of olfactory anatomic structures between patients diagnosed with COVID-19 associated with persistent olfactory dysfunction and healthy controls. MATERIALS AND METHODS: This study has a retrospective design. Cranial MR imaging was performed on all participants in both the patient and control groups. The bilateral olfactory bulb volume, olfactory tract length, and olfactory sulcus depth were measured in all patients. RESULTS: A total of 116 people aged 18-60 years, including 36 patients diagnosed with COVID-19 and 80 controls, were included in the study. All measured values were compared between the patient and control groups. The right, left, and total olfactory bulb volume values were significantly lower in the patient group than in the control group. The patient group also had significantly lower right and left olfactory sulcus depth and olfactory tract length values compared with those in the control group. CONCLUSIONS: MR imaging findings can be used to demonstrate olfactory injury in patients with COVID-19. The olfactory pathway may represent an alternative route for virus entry into the central nervous system.
Authors: David H Brann; Tatsuya Tsukahara; Caleb Weinreb; Marcela Lipovsek; Koen Van den Berge; Boying Gong; Rebecca Chance; Iain C Macaulay; Hsin-Jung Chou; Russell B Fletcher; Diya Das; Kelly Street; Hector Roux de Bezieux; Yoon-Gi Choi; Davide Risso; Sandrine Dudoit; Elizabeth Purdom; Jonathan Mill; Ralph Abi Hachem; Hiroaki Matsunami; Darren W Logan; Bradley J Goldstein; Matthew S Grubb; John Ngai; Sandeep Robert Datta Journal: Sci Adv Date: 2020-07-24 Impact factor: 14.136
Authors: Jerome R Lechien; Carlos M Chiesa-Estomba; Daniele R De Siati; Mihaela Horoi; Serge D Le Bon; Alexandra Rodriguez; Didier Dequanter; Serge Blecic; Fahd El Afia; Lea Distinguin; Younes Chekkoury-Idrissi; Stéphane Hans; Irene Lopez Delgado; Christian Calvo-Henriquez; Philippe Lavigne; Chiara Falanga; Maria Rosaria Barillari; Giovanni Cammaroto; Mohamad Khalife; Pierre Leich; Christel Souchay; Camelia Rossi; Fabrice Journe; Julien Hsieh; Myriam Edjlali; Robert Carlier; Laurence Ris; Andrea Lovato; Cosimo De Filippis; Frederique Coppee; Nicolas Fakhry; Tareck Ayad; Sven Saussez Journal: Eur Arch Otorhinolaryngol Date: 2020-04-06 Impact factor: 2.503
Authors: Sarah C Parauda; Virginia Gao; Alexandra N Gewirtz; Neal S Parikh; Alexander E Merkler; Joshua Lantos; Halina White; Dana Leifer; Babak B Navi; Alan Z Segal Journal: J Neurol Sci Date: 2020-07-09 Impact factor: 3.181
Authors: Andrew Chiu; Nancy Fischbein; Max Wintermark; Greg Zaharchuk; Paul T Yun; Michael Zeineh Journal: Neuroradiology Date: 2020-09-15 Impact factor: 2.995
Authors: Geidy E Serrano; Jessica E Walker; Cécilia Tremblay; Ignazio S Piras; Matthew J Huentelman; Christine M Belden; Danielle Goldfarb; David Shprecher; Alireza Atri; Charles H Adler; Holly A Shill; Erika Driver-Dunckley; Shyamal H Mehta; Richard Caselli; Bryan K Woodruff; Chadwick F Haarer; Thomas Ruhlen; Maria Torres; Steve Nguyen; Dasan Schmitt; Steven Z Rapscak; Christian Bime; Joseph L Peters; Ellie Alevritis; Richard A Arce; Michael J Glass; Daisy Vargas; Lucia I Sue; Anthony J Intorcia; Courtney M Nelson; Javon Oliver; Aryck Russell; Katsuko E Suszczewicz; Claryssa I Borja; Madison P Cline; Spencer J Hemmingsen; Sanaria Qiji; Holly M Hobgood; Joseph P Mizgerd; Malaya K Sahoo; Haiyu Zhang; Daniel Solis; Thomas J Montine; Gerald J Berry; Eric M Reiman; Katharina Röltgen; Scott D Boyd; Benjamin A Pinsky; James L Zehnder; Pierre Talbot; Marc Desforges; Michael DeTure; Dennis W Dickson; Thomas G Beach Journal: J Neuropathol Exp Neurol Date: 2022-08-16 Impact factor: 3.148
Authors: Alexandr Meshkov; Anvar Khafizov; Alexey Buzmakov; Inna Bukreeva; Olga Junemann; Michela Fratini; Alessia Cedola; Marina Chukalina; Andrei Yamaev; Giuseppe Gigli; Fabian Wilde; Elena Longo; Victor Asadchikov; Sergey Saveliev; Dmitry Nikolaev Journal: Tomography Date: 2022-07-22